0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects

PURPOSE: To compare the preservative-free corticosteroid 0.2% betamethasone sodium phosphate BID (SURF-201) to vehicle BID in patients undergoing routine cataract surgery. METHODS: Phase 2, multicenter, randomized (1:1 ratio), double-masked, vehicle-controlled, parallel-group study in patients sched...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosseini, Kamran, Gollamudi, Subba, Reiser, Harvey, Walters, Tom, Lindstrom, Richard L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411451/
https://www.ncbi.nlm.nih.gov/pubmed/37564159
http://dx.doi.org/10.2147/OPTH.S419857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10411451/
https://www.ncbi.nlm.nih.gov/pubmed/37564159
http://dx.doi.org/10.2147/OPTH.S419857

Ejemplares similares